Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06813118
PHASE1

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

Sponsor: HITEC-Institute of Medical Sciences

View on ClinicalTrials.gov

Summary

Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.

Official title: A RCT Comparing the Effectiveness of a Combination Therapy of Lezra and Clomid Versus Lezra Alone for Inducing Ovulation in Women Diagnosed With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

42

Start Date

2024-06-07

Completion Date

2025-03

Last Updated

2025-02-06

Healthy Volunteers

Yes

Interventions

DRUG

Clomiphene Citrate and letrozole

clomiphene citrate 100mg once daily along with letrozole 5mg to one group and letrozole 5mg to second group

Locations (1)

HIT Hospital

Rawalpindi, Punjab Province, Pakistan